Quantcast
Last updated on April 18, 2014 at 14:44 EDT

Latest Heerlen Stories

2014-02-04 16:23:29

PARSIPPANY, N.J., Feb. 4, 2014 /PRNewswire/ -- DSM Nutritional Products, a subsidiary of Royal DSM, the global Life Sciences and Materials Sciences company, announced today that it has entered into a collaboration with SyntheZyme LLC under a Development and Option to License Agreement to develop products based on SyntheZyme LLC's biosurfactant platform. For decades, the production of surfactants for an array of application areas such as agrochemicals, photo chemicals, oil field...

2014-01-23 16:25:21

ELGIN, Ill., Jan. 23, 2014 /PRNewswire/ -- Royal DSM, the global Life Sciences and Materials Sciences Company, has won an appeal regarding the opposition of patent EP1232198, titled, UV Curable Compositions at the European Patent Office Board of Appeal in Munich, Germany on January 17, 2014. This patent, currently assigned to 3D Systems, Inc., was revoked at the European level, thus allowing for increased development of materials in this field. (Logo:...

2013-10-29 20:22:45

PARSIPPANY, N.J., Oct. 29, 2013 /PRNewswire/ -- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), today officially opens its new cGMP facility for biopharmaceutical contract manufacturing in Brisbane, Australia. The facility was built in partnership with Biopharmaceuticals Australia with cooperation from the government of Queensland and the Commonwealth of Australia. This world-class operation in the Asia-Pacific...

2013-10-24 04:21:25

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE Euronext: DSM KON), announced today that it has signed a manufacturing agreement for commercial supply with Sanquin Blood Supply Foundation, The Netherlands. PARSIPPANY, N.J., Oct. 24, 2013 /PRNewswire/ -- The agreement covers the commercial manufacture of a monoclonal antibody used for the recovery and purification of coagulation factor IX from human blood. Factor IX is a protein...

2013-10-10 23:26:20

Solix Biosystems appoints new executive to drive commercial deployment of its proprietary AGS® technology for nutrition, personal care, and specialty chemical products Fort Collins, Colorado (PRWEB) October 10, 2013 Joel Butler, CEO of Solix BioSystems, Inc. (“Solix”), an algal technology company based in Fort Collins, Colorado, announced the appointment of James Tuan as its new Executive Vice President of Business Development. “As Solix transitions to expand focus from algal...

2013-04-22 04:21:07

PARSIPPANY, N.J., April 22, 2013 /PRNewswire/ -- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed an agreement with venture capital funded DecImmune Therapeutics of Cambridge, Massachusetts, USA The agreement covers the initiation of development activities by DSM for DecImmune's lead monoclonal antibody program. The initial development will be performed at DSM Biologics' Groningen, the...

2013-04-22 04:21:04

DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that their new cGMP custom biopharmaceutical manufacturing 'biologics plant of the future' will open in June 2013. PARSIPPANY, N.J., April 22, 2013 /PRNewswire/ -- The DSM facility was built with cooperation from the Queensland and Commonwealth Governments of Australia. Karen King, President of DSM Biologics, the biopharmaceutical manufacturing...

2013-03-11 12:24:59

PARAMUS, N.J., March 11, 2013 /PRNewswire/ -- Oceans Omega LLC, a leading supplier of stabilized omega-3 EPA and DHA ingredients to the dietary supplement, food and beverage markets, announced today that it has entered into a supply agreement with DSM Nutritional Products for the production of Oceans Omega's OTEC(TM) emulsion ingredients. DSM Nutritional Products is the world's leading supplier of omega-3 fatty acids, vitamins, carotenoids and other ingredients to the feed, food, dietary...

2013-02-19 12:31:04

PARSIPPANY, N.J., Feb. 19, 2013 /PRNewswire/ -- DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed a collaboration agreement with Chemtrix B.V., The Netherlands, in the field of Continuous Flow Chemistry. The Collaboration will provide equipment, development and manufacturing services to the pharmaceutical industry, resulting in novel, sustainable production methods. The agreement...

2013-01-15 04:21:13

PARSIPPANY, N.J., Jan. 15, 2013 /PRNewswire/ -- Karen King, President of DSM Biologics, commented "We are pleased to enter into this license agreement with Amgen, a global leader in biopharmaceutical drug development and manufacturing. We believe our proprietary XD(®) technology will play an important role in the next generation of biopharmaceutical manufacturing." XD(®) technology is a highly intensified cell culture process with typical titer achievement of 8-to-10 times higher...